Dual-energy X-ray absorptiometry measures of lean body mass as a biomarker for progression in boys with Duchenne muscular dystrophy

We evaluated whether whole-body dual-energy X-ray absorptiometry (DXA) measures of lean body mass can be used as biomarkers for disease progression and treatment effects in patients with Duchenne muscular dystrophy. This post hoc analysis utilized data from a randomized, 2-period study of domagrozum...

Descripción completa

Detalles Bibliográficos
Autores principales: Sherlock, Sarah P., Palmer, Jeffrey, Wagner, Kathryn R., Abdel-Hamid, Hoda Z., Tian, Cuixia, Mah, Jean K., Muntoni, Francesco, Guglieri, Michela, Butterfield, Russell J., Charnas, Lawrence, Marraffino, Shannon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637094/
https://www.ncbi.nlm.nih.gov/pubmed/36335191
http://dx.doi.org/10.1038/s41598-022-23072-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637094/
https://www.ncbi.nlm.nih.gov/pubmed/36335191
http://dx.doi.org/10.1038/s41598-022-23072-5

Ejemplares similares